Retinoblastoma Survivors: Sarcomas and Surveillance

Journal of the National Cancer Institute

Volumn 99, Issue 1, 2007, Pages 3-5

  Meadows, Anna T ^a  

^a CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; CANCER EPIDEMIOLOGY; CANCER INCIDENCE; CANCER RADIOTHERAPY; CANCER SURVIVOR; EDITORIAL; EXTERNAL BEAM RADIOTHERAPY; GENE MUTATION; GENETIC PREDISPOSITION; HUMAN; LEIOMYOSARCOMA; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RADIATION DOSE; RETINOBLASTOMA; RHABDOMYOSARCOMA; SOFT TISSUE SARCOMA; ADJUVANT CHEMOTHERAPY; ADJUVANT THERAPY; GENETICS; HEALTH SURVEY; INCIDENCE; MUTATION; NOTE; RADIOTHERAPY; SARCOMA; SECOND CANCER; STATISTICS; SURVIVOR; UNITED STATES;

CHEMOTHERAPY, ADJUVANT; GERM-LINE MUTATION; HUMANS; INCIDENCE; NEOPLASMS, SECOND PRIMARY; POPULATION SURVEILLANCE; RADIOTHERAPY; RADIOTHERAPY, ADJUVANT; RETINOBLASTOMA; SARCOMA; SURVIVORS; UNITED STATES;

EID: 33846960194     PISSN: 00278874     EISSN: 14602105     Source Type: Journal    
DOI: 10.1093/jnci/djk014     Document Type: Editorial

References (21)

1. Tucker MA, Meadows AT, Boice JD, Hoover RN, Fraumeni JF. Cancer risk following treatment of childhood cancer. In: Fraumeni JF, Boice JD, editors. Radiation carcinogenesis: epidemiology and biological significance. New York, NY: Raven Press; 1984. p. 211-24.
2. Meadows AT, Baum E, Fossati-Bellani F, Green D, Jenkin RD, Marsden B, et al. Second malignant neoplasms in children: an update from the Late Effects Study Group. J Clin Oncol 1985;3:532-8.
3. Friend SH, Bernards R, Rogelj S, Weinberg RA, Rapaport JM, Albert DM, et al. A human DNA segment with properties of the gene that predisposes to retinoblastoma and osteosarcoma. Nature 1986;323:643-6.
4. Shirodkar S, Ewen M, DeCaprio JA, Morgan J, Livingston DM, Chittenden T. The transcription factor E2F interacts with the retinoblas- toma product and a p107-cyclin A complex in a cell cycle-regulated manner. Cell 1992;68:157-66.
5. Sagerman RH, Cassady JR, Tretter P, Ellsworth RM. Radiation induced neoplasia following external beam therapy for children with retinoblas-toma. Am J Roentgenol Radium Ther Nucl Med 1969;105:529-35.
6. Strong LC, Knudson AG Jr. Letter: second cancers in retinoblastoma. Lancet 1973;2:1086.
7. Kleinerman RA, Tucker MA, Abramson DH, Seddon JM, Tarone RE, Fraumeni JF Jr. Risk of soft tissue sarcomas by individual subtype in survivors of hereditary retinoblastoma. J Natl Cancer Inst 2007;99:24-31.
8. Kleinerman RA, Tucker MA, Tarone RE, Abramson DH, Seddon JM, Stovall M, et al. Risk of new cancers after radiotherapy in long-term survivors of retinoblastoma: an extended follow-up. J Clin Oncol 2005;23: 2272-9.
9. Eng C, Li FP, Abramson DH, Ellsworth RM, Wong FL, Goldman MB, et al. Mortality from second tumors among long-term survivors of retino- blastoma. J Natl Cancer Inst 1993;85:1121-8.
10. Abramson DH, Ellsworth RM, Zimmerman LE. Nonocular cancer in retinoblastoma survivors. Trans Sect Ophthalmol Am Acad Ophthalmol Otolaryngol 1976;81:454-7.
11. Kaste SC, Chen G, Fontanesi J, Crom DB, Pratt CB. Orbital development in long-term survivors of retinoblastoma. J Clin Oncol 1997;15:1183-9.
12. Bhatia S, Yasui Y, Robison LL, Birch JM, Bogue MK, Diller L, et al. High risk of subsequent neoplasms continues with extended follow-up of childhood Hodgkin's disease: report from the Late Effects Study Group. J Clin Oncol 2003;21:4386-94.
13. Kenney LB, Yasui Y, Inskip PD, Hammond S, Neglia JP, Mertens AC, et al. Breast cancer after childhood cancer: a report from the Childhood Cancer Survivor Study. Ann Intern Med 2004;141:590-7.
14. Bassal M, Mertens AC, Taylor L, Neglia JP, Greffe BS, Hammond S, et al. Risk of selected subsequent carcinomas in survivors of childhood cancer: a report from the Childhood Cancer Survivor Study. J Clin Oncol 2006;24:476-83.
15. Nichols KE, Houseknecht MD, Godmilow L, Bunin G, Shields C, Meadows A, et al. Sensitive multistep clinical molecular screening of 180 unrelated individuals with retinoblastoma detects 36 novel mutations in the RB1 gene. Hum Mutat 2005;25:566-74.
16. Richter S, Vandezande K, Chen N, Zhang K, Sutherland J, Anderson J, et al. Sensitive and efficient detection of RB1 gene mutations enhances care for families with retinoblastoma. Am J Hum Genet 2003;72:253-69.
17. Chantada GL, Fandino AC, Raslawski EC, Manzitti J, de Davila MT, Casak SJ, et al. Experience with chemoreduction and focal therapy for intraocular retinoblastoma in a developing country. Pediatr Blood Cancer 2005;44:455-60.
18. Rodriguez-Galindo C, Wilson MW, Haik BG, Merchant TE, Billups CA, Shah N, et al. Treatment of intraocular retinoblastoma with vincristine and carboplatin. J Clin Oncol 2003;21:2019-25.
19. Chan HS, DeBoer G, Thiessen JJ, Budning A, Kingston JE, O'Brien JM, et al. Combining cyclosporin with chemotherapy controls intraocular retinoblastoma without requiring radiation.Clin Cancer Res 1996;2:1499-508.
20. Friedman DL, Himelstein B, Shields CL, Shields JA, Needle M, Miller D, et al. Chemoreduction and local ophthalmic therapy for intraocular retinoblastoma. J Clin Oncol 2000;18:12-7.
21. Shields CL, Mashayekhi A, Au AK, Czyz C, Leahey A, Meadows AT, et al. The International Classification of Retinoblastoma predicts chemoreduction success. Ophthalmology 2006;113:2276-80.